Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 23, 2022 - Issue 12
Submit an article Journal homepage
462
Views
1
CrossRef citations to date
0
Altmetric
Review

On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future

Vincent Sunder-Plassmanna Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences. Dr. Karl-Dorrek-Straße 30, 3500Krems an der Donau, AustriaView further author information
,
Osman Aksoya Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences. Dr. Karl-Dorrek-Straße 30, 3500Krems an der Donau, AustriaView further author information
,
Judith Linda Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences. Dr. Karl-Dorrek-Straße 30, 3500Krems an der Donau, AustriaView further author information
,
Martin Pecherstorferb Department of Internal Medicine 2, University Hospital Krems, Mitterweg 10, 3500Krems an der Donau, AustriaView further author information
,
Sonia Valleta Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences. Dr. Karl-Dorrek-Straße 30, 3500Krems an der Donau, Austria;b Department of Internal Medicine 2, University Hospital Krems, Mitterweg 10, 3500Krems an der Donau, AustriaView further author information
&
Klaus Podara Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences. Dr. Karl-Dorrek-Straße 30, 3500Krems an der Donau, Austria;b Department of Internal Medicine 2, University Hospital Krems, Mitterweg 10, 3500Krems an der Donau, AustriaCorrespondence[email protected]
View further author information
Pages 1425-1444 | Received 05 Apr 2022, Accepted 11 Jul 2022, Published online: 10 Aug 2022

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (1)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.